Latest AI and machine learning research in dementia for healthcare professionals.
Neurodegenerative diseases (NDs), characterized by progressive neuronal degeneration and manifesting in diverse forms such as memory loss and movement disorders, pose significant challenges due to their complex molecular mechanisms and heterogeneous patient presentations. Diagnosis often relies heavily on clinical assessments and neuroimaging, with definitive confirmation frequently requiring post...
OBJECTIVE: Dementia represents a growing public health challenge, affecting an increasing number of individuals. It encompasses a broad spectrum of cognitive impairments, ranging from mild to severe stages, each of which demands varying levels of care. Current diagnostic approaches often treat dementia as a uniform condition, potentially overlooking clinically significant subtypes, which limits th...
BACKGROUND: Sarcopenia (loss of muscle mass and strength) increases adverse outcomes risk and contributes to cognitive decline in older adults. Accura...
Comorbid cardiovascular and metabolic risk factors (CVM) differentially impact brain structure and increase dementia risk, but their specific magnetic...
Multiple imaging modalities and specific proteins in the cerebrospinal fluid, providing a comprehensive understanding of neurodegenerative disorders, ...
Detection of Alzheimer's Disease (AD) is critical for successful diagnosis and treatment, involving the common practice of screening for Mild Cognitiv...
ObjectiveTo evaluate the readability of online patient education materials (PEMs) for cleft lip and/or palate and assess their alignment with recommen...
This protocol outlines a systematic review and meta-analysis examining the effectiveness of fully automated, AI-driven chatbot interventions in reduci...
BACKGROUND: Early prediction of progression in dementia is of major importance for providing patients with adequate clinical care, with considerable i...
An interpretable machine learning (ML) framework is introduced to enhance the diagnosis of Mild Cognitive Impairment (MCI) and Alzheimer's disease (AD...
BACKGROUND: The application of intelligent robots in therapy is becoming more and more important for people with dementia. More extensive research is ...
BACKGROUND: Dementia is a multifaceted disorder that affects cognitive function, necessitating accurate diagnosis for effective management and treatme...
BACKGROUND: Integrating machine learning with medical records offers potential for early detection of Alzheimer's disease (AD), enabling timely interv...
Mild cognitive impairment (MCI) is a clinical condition characterized by a decline in cognitive ability and progression of cognitive impairment. It is...
BACKGROUND AND OBJECTIVE: Alzheimer's disease (AD) significantly threatens community well-being and healthcare resource allocation due to its high inc...
Alzheimer's disease (AD) is a severe neurological illness that demolishes memory and brain functioning. This disease affects an individual's capacity ...
The immersive experience provided by our approach empowers researchers with an intuitive exploration of brain structures. Within the brain's central n...
BACKGROUND: Dementia is a neurological syndrome marked by cognitive decline. Alzheimer's disease (AD) and frontotemporal dementia (FTD) are the common...
Recent advancements in the classification of Alzheimer's disease have leveraged the automatic feature generation capability of convolutional neural ne...
The Morris Water Maze (MWM) is a widely used behavioral test to assess the spatial learning and memory of animals, particularly valuable in studying n...